About Wave Life Sciences Ltd.

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

At the moment the company generates 17M USD in revenues.

On its last earning announcement, the company reported a loss of -5.74$ per share.

The book value per share is 3.35$

Wave Life Sciences Ltd. website

Create a solid portfolio with WVE

Add WVE to your portfolio and optimize it!


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
17M - -210M - -197M -5.74 - - 34M 3.35 -164M -4M -168M